SCHEMBL4619413

SCHEMBL4619413

COc1ccccc1CCNS(=O)(=O)c1cc(S(=O)(=O)c2ccccc2)ccc1OC

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SFRP1 Q8N474 3/20 0.66
SMN1; SMN2 Q16637 3/20 0.56
ALDH1A1 P00352 2/20 0.56
HTT P42858 1/20 0.55
CA12 O43570 1/20 0.54
CA1 P00915 1/20 0.54
CA2 P00918 1/20 0.54
CA5A P35218 1/20 0.54
CA9 Q16790 1/20 0.54
CA14 Q9ULX7 1/20 0.54
KDM4E B2RXH2 2/20 0.53
CYP1A2 P05177 1/20 0.53
CYP3A4 P08684 1/20 0.53
CYP2C9 P11712 1/20 0.53
CYP2C19 P33261 1/20 0.53
ALOX15 P16050 1/20 0.53
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
HTR6 P50406 1/20 0.48
MAPT P10636 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4617383 0.91 SFRP1 (0.69) SFRP1SMN1; SMN2ALDH1A1HTTCA12
SCHEMBL4616812 0.91 SFRP1 (0.76) SFRP1SMN1; SMN2ALDH1A1HTTCA12
SCHEMBL4619774 0.90 SFRP1 (0.62) SFRP1SMN1; SMN2ALDH1A1HTTKDM4E
SCHEMBL4616713 0.89 CA12 (0.58) SFRP1SMN1; SMN2ALDH1A1HTTCA12
SCHEMBL4617736 0.88 ALDH1A1 (0.72) SFRP1SMN1; SMN2ALDH1A1HTTKDM4E
SCHEMBL4616128 0.85 SFRP1 (0.61) SFRP1ALDH1A1HTTCA12CA1
SCHEMBL4618123 0.85 SFRP1 (0.84) SFRP1SMN1; SMN2ALDH1A1HTTCA12
SCHEMBL6102307 0.84 SFRP1 (0.60) SFRP1SMN1; SMN2ALDH1A1CA12CA1
SCHEMBL4617608 0.84 SMN1; SMN2 (0.63) SFRP1SMN1; SMN2ALDH1A1HTTKDM4E
SCHEMBL4619170 0.84 SFRP1 (0.59) SFRP1SMN1; SMN2ALDH1A1HTTCA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof WYETH (US) 2006-12-07 US claimed
EP-1879859-A2 DIARYLSULFONE SULFONAMIDES AND USE THEROF Wyeth a Corporation of the State of Delaware (US) 2008-01-23 EP disclosed
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof WYETH (US) 2006-12-07 US disclosed
WO-2006124875-A2 DIARYLSULFONE SULFONAMIDES AND USE THEROF WYETH (US) 2006-11-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060276464-A1 Diarylsulfone sulfonamides and use thereof SFRP1, SOS1, FZD7 SFRP1 1/4885SMN1; SMN2 2404/4885ALDH1A1 1865/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.